AIMC Topic: Drug Discovery

Clear Filters Showing 141 to 150 of 1689 articles

GraphCF: Drug-target interaction prediction via multi-feature fusion with contrastive graph neural network.

Artificial intelligence in medicine
Drug-target interaction (DTI) is paramount in drug discovery and repurposing, which involves screening for effective candidate drugs by targeting specific proteins. Existing methods often focus on one or two representations of drugs or targets, and l...

Artificial intelligence-driven discovery of novel scaffolds for selective TLR7 antagonists and their application in enhancing mRNA translation efficiency.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Toll-like receptor 7 (TLR7) is crucial in the innate immune response, responsible for recognizing single-stranded RNA from external pathogens and initiating the production of inflammatory cytokines and type I interferons. Despite the potential therap...

AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy.

Pharmacological research
Galectin-3 (Gal-3) has emerged as a critical regulator of neuroinflammation and a promising therapeutic target for Alzheimer's disease (AD). Nevertheless, the development of brain-penetrant small-molecule Gal-3 inhibitors poses a significant challeng...

Molecular dynamics-driven drug discovery.

Physical chemistry chemical physics : PCCP
Molecular dynamics (MD) simulation is an important tool and has a wide range of applications in many scientific fields, including drug discovery. Herein, focusing on drug discovery, the early compound discovery stage in particular, we discuss some of...

Advancing active compound discovery for novel drug targets: insights from AI-driven approaches.

Acta pharmacologica Sinica
The discovery of active compounds for novel, underexplored targets is essential for advancing innovative therapeutics across a wide range of diseases. Recent advancements in artificial intelligence (AI) are revolutionizing active compound discovery b...

Improved Prediction of Drug-Protein Interactions through Physics-Based Few-Shot Learning.

Journal of chemical information and modeling
Accurate prediction of drug-protein interactions is crucial for drug discovery. Due to the bottleneck of traditional scoring functions, many machine learning scoring functions (MLSFs) have been proposed for structure-based drug screening. However, ex...

LumiCharge: Spherical Harmonic Convolutional Networks for Atomic Charge Prediction in Drug Discovery.

The journal of physical chemistry letters
Atomic charge is crucial in drug design for analyzing reactive sites and interactions between ligands and targets. While quantum mechanical methods offer high accuracy, they are generally computationally costly. Conversely, empirical approaches, whil...

Discovery of Novel Anti-Acetylcholinesterase Peptides Using a Machine Learning and Molecular Docking Approach.

Drug design, development and therapy
OBJECTIVE: Alzheimer's disease poses a significant threat to human health. Currenttherapeutic medicines, while alleviate symptoms, fail to reverse the disease progression or reduce its harmful effects, and exhibit toxicity and side effects such as ga...

Contrastive learning-based drug screening model for GluN1/GluN3A inhibitors.

Acta pharmacologica Sinica
GluN3A-containing NMDA receptors have recently emerged as promising therapeutic targets for neurological disorders. However, discovering potent modulators remains a significant challenge, primarily due to the limitations of traditional high-throughpu...

Quantum Machine Learning in Drug Discovery: Applications in Academia and Pharmaceutical Industries.

Chemical reviews
The nexus of quantum computing and machine learning─quantum machine learning─offers the potential for significant advancements in chemistry. This Review specifically explores the potential of quantum neural networks on gate-based quantum computers wi...